Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Malignant Neoplasms of Digestive Organs × gimeracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Stomach Neoplasms 4 Pancreatic Neoplasms 2 Rectal Neoplasms 1 Malignant Neoplasms of Digestive Organs 1 Head and Neck Neoplasms 1 Fruquintinib 1 Esophageal Squamous Cell Carcinoma 1 Esophageal 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Apatinib Combined 1 Advanced Pancreatic Cancer 1

Interventions

toripalimab 1 potassium oxonate 1 gimeracil 1 apatinib 1 Tegafur 1 Nivolumab 1 Gemcitabine 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05934331 2025-09-12

A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

LaNova Medicines Limited

Phase 2 Recruiting

Malignant Neoplasms of Digestive Organs

Data powered by HemOnc (CC BY 4.0) Colophon ⚡